N. Bedini
CCL2Motion (physics)Internal medicineRadiologyUrologyPTX3ChemokineSurgeryAssociation (psychology)OncologyOutcome (game theory)Dose fractionationNursingTumor necrosis factor alphaDecision analysisBasal (phylogenetics)Physical therapyEmergency medicineMedical physicsCohort studyClinical endpointAlternative medicineMultidisciplinary approachObservational studyExternal beam radiotherapyBiopsyPatient satisfactionProstateBrachytherapyCarcinomaAttendanceResponse rate (survey)Hormonal therapyPelvisTolerabilityContouringDiseaseProstatectomyMEDLINEUrinary bladderQuality of life (healthcare)Context (language use)Abdominal surgeryGuidelineProstate cancerBladder cancerProtocol (science)SAINTManagement of prostate cancerAdenocarcinomaProstate-specific antigenCompliance (psychology)External Radiation TherapyPopulationUrinary symptomsHeavy Ion RadiotherapyNeoplasm GradingProstate radiotherapyGynecologyToxicityElectromagnetic trackingNuclear medicineProstate adenocarcinomaMedical physicistPersonal interestMuscle invasiveIntrafraction motionRepeat biopsyBladder preservationTreatment optionsSingle fractionInflammatory responseCombined treatmentDisease free survivalBreathingCarbonProportional hazards modelRadiation therapyClinical trialGut floraMedical emergencyScheduleMedicineBiologyMicrobiologyPhysical medicine and rehabilitation
20Publications
5H-index
80Citations
Publications 15
Newest
#1N. BediniH-Index: 5
#2Alessandro Cicchetti (UNIPV: University of Pavia)H-Index: 7
Last. Riccardo Valdagni (University of Milan)H-Index: 51
view all 16 authors...
A recent “hot topic” in prostate cancer radiotherapy is the observed association between acute/late rectal toxicity and the presence of abdominal surgery before radiotherapy. The exact mechanism is unclear. Our working hypothesis was that a previous surgery may influence plasma level of inflammatory molecules and this might result in enhanced radiosensitivity. We here present results on the feasibility of monitoring the expression of inflammatory molecules during radiotherapy. Plasma levels of a...
7 CitationsSource
#1Tommaso GiandiniH-Index: 4
#2C. Tenconi (IEO: European Institute of Oncology)H-Index: 6
Last. Emanuele PignoliH-Index: 19
view all 21 authors...
BackgroundThis study was based on a survey to investigate perceptions of hadrontherapy of the members of the Italian Association of Medical Physics (AIFM). The survey was digitally submitted to the 991 members between the end of January and the beginning of April 2016.MethodsA 19-item questionnaire was designed focusing on advantages and disadvantages of hadrontherapy, current status and possible future improvements, and need and opportunities for future investments in Italy and abroad. Informat...
Source
#1C. MarenghiH-Index: 6
Last. Riccardo Valdagni (University of Milan)H-Index: 51
view all 34 authors...
PurposeTo evaluate the outcomes of active surveillance (AS) on patients with low-risk prostate cancer (PCa) and to identify predictors of disease reclassification.MethodsIn 2005, we defined an inst...
9 CitationsSource
#1Giulia Marvaso (IEO: European Institute of Oncology)H-Index: 14
#2Barbara Alicja Jereczek-Fossa (IEO: European Institute of Oncology)H-Index: 36
Last. Roberto Orecchia (IEO: European Institute of Oncology)H-Index: 71
view all 23 authors...
PURPOSE: Definition of the optimal treatment schedule for high-risk prostate cancer is under debate. A combination of photon intensity modulated radiotherapy (IMRT) on pelvis with a carbon ion boost might be the optimal treatment scheme to escalate the dose on prostate and deliver curative dose with respect to normal tissue and quality of dose distributions. In fact, carbon ion beams offer the advantage to deliver hypofractionated radiotherapy (RT) using a significantly smaller number of fractio...
7 CitationsSource
#1F. BadenchiniH-Index: 3
#2Federica PaloriniH-Index: 11
Last. R. ValdagniH-Index: 4
view all 21 authors...
Source
#1Tommaso GiandiniH-Index: 4
Last. Mauro CarraraH-Index: 16
view all 13 authors...
PurposeTo validate and apply a method for the quantification of breathing-induced prostate motion (BIPM) for patients treated with radiotherapy and implanted with electromagnetic transponders for p...
Source
#1Mauro CarraraH-Index: 16
#1M CarraraH-Index: 6
Last. E PignoliH-Index: 1
view all 11 authors...
The Calypso tracking system (Varian, Palo Alto, CA, USA) is used to track the prostate isocenter on patients undergoing prostate radiotherapy after implantation of electromagnetic transponders. Aim of this study was to assign 226 recorded prostate tracks to different patterns of prostate intrafraction motion (i.e. stable target (ST), continuous target drift (CTD) and irregular wave motion (IWM)) and excursion (i.e. transient excursion (TE), persistent excursion (PE) and high-frequency excursion ...
1 CitationsSource
Source
#2Tommaso GiandiniH-Index: 4
Last. Emanuele PignoliH-Index: 19
view all 12 authors...
Introduction A system (Calypso, Varian Medical Systems) based on the localization of electromagnetic transponders (ELM-TRNs) permanently implanted in the prostate allows real-time tracking during radiotherapy treatments. Purpose Development and validation of a dedicated software for ELM-TRNs signal analysis to quantify the amplitude of the intra-fraction prostate motion induced by patient’s breathing, both in supine and prone position. Materials and methods For each treatment session, the softwa...
Source
#1Tommaso GiandiniH-Index: 4
#2C.M.V. Panaino (University of Milan)
Last. Emanuele PignoliH-Index: 19
view all 13 authors...
Source